Jbara-Agbaria, D.; Blondzik, S.; Burger-Kentischer, A.; Agbaria, M.; Nordling-David, M.M.; Giterman, A.; Aizik, G.; Rupp, S.; Golomb, G.
Liposomal siRNA Formulations for the Treatment of Herpes Simplex Virus-1: In Vitro Characterization of Physicochemical Properties and Activity, and In Vivo Biodistribution and Toxicity Studies. Pharmaceutics 2022, 14, 633.
https://doi.org/10.3390/pharmaceutics14030633
AMA Style
Jbara-Agbaria D, Blondzik S, Burger-Kentischer A, Agbaria M, Nordling-David MM, Giterman A, Aizik G, Rupp S, Golomb G.
Liposomal siRNA Formulations for the Treatment of Herpes Simplex Virus-1: In Vitro Characterization of Physicochemical Properties and Activity, and In Vivo Biodistribution and Toxicity Studies. Pharmaceutics. 2022; 14(3):633.
https://doi.org/10.3390/pharmaceutics14030633
Chicago/Turabian Style
Jbara-Agbaria, Doaa, Saskia Blondzik, Anke Burger-Kentischer, Majd Agbaria, Mirjam M. Nordling-David, Anna Giterman, Gil Aizik, Steffen Rupp, and Gershon Golomb.
2022. "Liposomal siRNA Formulations for the Treatment of Herpes Simplex Virus-1: In Vitro Characterization of Physicochemical Properties and Activity, and In Vivo Biodistribution and Toxicity Studies" Pharmaceutics 14, no. 3: 633.
https://doi.org/10.3390/pharmaceutics14030633
APA Style
Jbara-Agbaria, D., Blondzik, S., Burger-Kentischer, A., Agbaria, M., Nordling-David, M. M., Giterman, A., Aizik, G., Rupp, S., & Golomb, G.
(2022). Liposomal siRNA Formulations for the Treatment of Herpes Simplex Virus-1: In Vitro Characterization of Physicochemical Properties and Activity, and In Vivo Biodistribution and Toxicity Studies. Pharmaceutics, 14(3), 633.
https://doi.org/10.3390/pharmaceutics14030633
